The NKI PhD recruitment program in Chromosome Biology & Gene Regulation aims to recruit outstanding, national and international PhD students, and provide them with excellent research training in a vibrant scientific environment. The main priorities of this program are the effective mentoring of PhD students and ensuring that all candidates have the support and resources they need to perform high-quality research. PhD students at the NKI enjoy access to top-level research facilities and receive training in science and career related aspects. Lecture series and weekly seminars provide PhD students with immediate access to many of the world’s most renowned scientists. The NKI with approximately 60 research groups is a fertile ground for stimulating encounters and a good spirit – not least socially.
Benjamin Rowland Group | Unravelling the mechanisms that structure chromosomes
The Rowland lab is looking for a motivated PhD student who will join our international and interdisciplinary team.
Research in the Rowland lab is driven by our fascination for how molecular machines such as cohesin and condensin can enable some of the most basic chromosomal processes. This ranges from chromosome segregation in mitosis, to the DNA folding in interphase that controls gene expression and DNA repair. The lab uses an interdisciplinary approach that involves genetics, genomics, biochemistry and imaging.
We are looking for an enthusiastic team-player, who enjoys discussing science, and who shares our passion for chromosome biology. The precise nature of the project will be determined following conversations with the PhD student to find the project that best matches the specific interests of the PhD student.
Thijn Brummelkamp Group | Experimental genetics
Whereas accurate maps exist depicting biochemical pathways, equivalent charts do not exist for the genetic wiring of human cells. This lack of knowledge provides a rich ground for biological discovery. Our goal is to create genetic tools for human cells and to apply these to address important biological questions. Specifically, we use haploid human cells as a genetic model system and apply insertional mutagenesis to link genes to phenotypes (Brockmann et al, 2017). In the last years we have used this approach to find host factors for pathogens (Staring et al, 2017), to identify essential genes and synthetic lethal interactions (Blomen et al, 2015), and to search for new genes relevant for immunotherapy (Mezzadra et al, 2017).
Currently we are using genetics in haploid human cells to discover missing enzymes in key cellular processes (Nieuwenhuis et al, 2017; Landskron et al, 2022) and to elucidate new signaling or metabolic pathways that may play a role in cancer. Integrated analysis of our growing genotype-phenotype database sheds light on the genetic regulatory mechanisms that control human cells.
We are looking for a highly enthusiastic PhD student to join our group. We provide a collaborative and ambitious research environment in the department of biochemistry at the Netherlands Cancer Institute.
Due to the Western lifestyle, the incidence of colorectal cancer is increasing yearly. This trend is especially prevalent among young individuals. Late-stage colorectal cancer poses significant challenges for treatment, making it crucial to prioritize prevention and find effective cures. Our objective is to develop prevention strategies by studying the early stages of tumorigenesis. We will focus on understanding the cellular and molecular mechanisms that enable mutant cells to survive and initiate early tumor growth.
Our laboratory has developed unique intravital microscopy technologies and fluorescent models to observe the behavior of individual cells in living mice. In this project, we will utilize these technologies to investigate the earliest phases of tumorigenesis, specifically focusing on the fate of mutant cells in healthy tissues. In addition to intravital microscopy, we will employ various other state-of-the-art technologies, including 3D imaging of cleared human and mouse tissues, imaging analysis, mouse genetics, organoid technology, and histological examination of patient samples.
While this is primarily a fundamental research project, the outcomes will have significant relevance for colorectal cancer patients. Therefore, whenever possible, we will seek collaborations with clinicians to ensure that any clinically significant findings are effectively utilized.
Tineke Lenstra group | Transcription dynamics in single cells
The main interest of the Lenstra lab is to understand the regulatory mechanisms and dynamics of eukaryotic transcription. Precise regulation of transcription is essential to ensure that the correct genes are expressed in the correct tissue at the correct time. Misregulation can result in diseases such as cancer. Understanding the molecular mechanisms that regulate transcription requires a dynamic view of the underlying process inside single cells. Such single-cell studies have shown that genes are transcribed in a highly dynamic manner, with bursts of transcription activity interspersed with periods of inactivity. In our lab, we use cutting-edge single-molecule microscopy techniques to directly visualize and quantify these transcriptional fluctuations inside single cells. In addition, we visualize the stochastic behavior of individual regulatory molecules, such as transcription factors, to understand how their transient DNA binding regulates transcription activation. We combine these microscopy methods with gene-specific and conditional perturbations, (single-cell) genomic experiments, single-molecule in vitro analyses, and computational approaches, using both budding yeast and mammalian cells as model systems. Using these techniques, the projects in the lab focus on understanding how transcription factors, cofactors, promoter and enhancer sequences and chromatin regulates transcription in a dynamic manner. Moreover, in collaboration with Jurgen Marteijns lab, we study the dynamics and fate of RNA polymerases when they encounter DNA damage during transcription. To push the field forward, we are also developing novel single-molecule microscopy techniques and kinetic analysis tools. Overall, by visualizing transcription dynamics in single cells, we aim to gain mechanistic insight into eukaryotic gene expression regulation in both health and disease.
Bas van Steensel Group | Tackling gene regulation by innovative genomics approaches
Our lab is fascinated by genome biology and gene regulation. What does an interphase chromosome look like? How do transcription factors, enhancers and promoters talk to each other? How are all ~30,000 genes in our genome coordinately regulated? And how can this go wrong in cancer? Clearly, the underlying molecular mechanisms and regulatory networks are very complex. But we believe we are in a good position to tackle this complexity, because our lab has developed a suite of unique, powerful genomics tools.
First, we use massively parallel reporter assays in combination with advanced computational methods such as deep learning to unravel the regulatory logic of enhancers and promoters, and to measure and predict the impact of sequence variation in human genomes. Second, we have built libraries of reporters that enable us to monitor the activity of dozens of transcription factors in parallel, thus elucidating the architecture of regulatory networks. Third, we develop a scalable, broadly applicable technology to systematically scramble a genomic locus of interest, either by 'hopping' enhancers and promoters to hundreds of alternative positions, or by inducing random inversions and deletions. This helps us to understand how the linear ordering of regulatory elements enables their functioning. Together, these tools place us in a unique position to unravel the multilayered regulation of gene expression in healthy and cancer cells.
Our lab is an interdisciplinary team of wet-lab and computational scientists. Several PhD projects are possible, as long as they (i) connect to other projects in the lab; (ii) fire up your enthusiasm, and (iii) match your talents.
Wilbert Zwart Group | Hormonal regulation, transcriptional control and epigenetics in cancer
The Zwartlab is specialized in hormonal regulation, transcriptional control and epigenetics in cancer. Our unique expertise involves a ‘full circle approach’, with most projects in the team spanning from clinical observation to mechanistic studies, discovery of novel biomarkers or therapeutic opportunities and back again to the clinic. Our main track record is on Androgen Receptor functioning in prostate cancer (Linder at al., 2022. Cancer Discovery; Pomerantz et al., 2020. Nature Genetics), Glucocorticoid Receptor signalling in lung cancer (Prekovic et al., 2021 Nature Communications) and Estrogen Receptor action in breast cancer (Severson et al. 2018 Nature Communications) and endometrial cancer (Droog et al., 2017 PNAS ).
As hormone receptors are acting through enhancer elements, we are particularly interested in enhancer-promoter interactions in 3D genomic space, identification of essential enhancers in tumor cell fitness, enhancer plasticity in tumor progression and the impact of somatic mutations on enhancer function. The PhD project is positioned on the intersection of wetlab functional genomics studies with bioinformatics, aimed to better understand how enhancer dynamics and hormone receptor action itself is changing upon cancer progression, and how such epigenetic plasticity contributes to acquired therapy resistance in cancer. Past experience in molecular biology and (epi)genomics is required, prior knowledge of bioinformatics and programming in R is a plus.
Step 1. Check whether you are eligible to participate
The eligibility criteria:
Step 2. Choose topics of your interest
Select one or more of the offered dissertation positions according to your interest. The available positions in this call can be found here.
Step 3. Prepare the required documents and video
Step 4. Submission
Step 1. Applicants submit the required documents and video
Applicants have to submit the application form, video (via WeTransfer) and CV to PhDprogram@nki.nl. The two referees should submit their references directly to PhDprogram@nki.nl. For more details about this step see how to apply.
Step 2. Eligibility and prescreening
After the call deadline, the PhD program committee will check whether the application is complete and carry out an eligibility check. Ineligible or incomplete applications will not be further evaluated, and the applicants will be informed.
Eligible and complete applications will continue to the prescreening. In the prescreening, the PhD program committee will score each candidate on the five items below. Only the highest scoring candidates, will be evaluated by the principal investigators participating in the program. The principal investigators will indicate their preferred candidates who can continue to the online interviews. Before the 16th of September, applicants will be informed via email whether they passed the prescreening and can continue to the online interviews.
Step 3. Online interviews
A panel of three or four researchers judge the candidate during the online interview.
Each online interview takes 45 minutes and consists of:
Afterwards there will be a 15 minutes panel discussion. The top candidates will be selected for the onsite interviews.
Step 4. Onsite interviews
The onsite visit includes a presentation by the candidate, meeting with the principal investigator and members of his/her research group, and visits to the institute, the lab and the facilities.
Step 5. Matching
After the onsite interviews, a matching will be made between the candidates and the principal investigators. Selected candidates can start the PhD by the end of 2023.
PhD students at the Netherlands Cancer Institute (NKI) will take part in the training program organized by the Oncology Graduate School Amsterdam (OOA): a collaboration between the NKI, the Amsterdam UMC, the University of Amsterdam and Vrije Universiteit Amsterdam.
The students follow the OOA training program consisting of courses, meet-the-expert sessions, and an annual retreat. The program includes in-depth courses on various topics in cancer research, as well as technical courses in English writing, biostatistics and -informatics, microscopy, and animal handling. Students with an insufficient background in cancer research can attend the Experimental Oncology course for Master students. PhD students will have the opportunity to meet experts in the field of oncology.
The annual PhD student retreat will focus entirely on the research of the PhD students themselves. First year students will present their work in the form of a poster, advanced students will give oral presentations. Importantly, students will be in charge of chairing sessions, monitoring discussions, and selecting who will win the prize for the best posters or presentations. In this way, the retreat provides not only an overview of the research in the OOA at an early stage of the student’s career, but also a training in presentation and interaction skills.
We hope to encourage translational interactions and bottom-up research, in which PhD students actively establish collaborations with other research groups, further strengthening scientific exchange between the Amsterdam oncology centers.
PhD students are free to enroll in another graduate school if this school provides a more suitable training program.
The Netherlands Cancer Institute (NKI) comprises an internationally acclaimed research institute as well as a dedicated cancer clinic. This combination ensures rapid translation of basic research into clinical applications: today’s research for tomorrow’s cure. As a researcher in our team you can also make an important scientific contribution to realizing our common goal.
Titia Gebuis & Mariet Dijkstra - van den Berg
Program coordinators
phdprogram@nki.nl
Visiting address
Plesmanlaan 121
1066 CX Amsterdam
We believe that excellent science can only be of value when it is based on trust, transparency, fairness, and equal opportunity. In our institute, we want our research to be responsible, in all possible respects.
We realize that this is an ongoing process of learning and doing, which starts with fostering an open, collaborative, and critical research environment. Read more.